Literature DB >> 9346881

pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).

W Swietnicki1, R Petersen, P Gambetti, W K Surewicz.   

Abstract

A recombinant protein corresponding to the human prion protein domain encompassing residues 90-231 (huPrP(90-231)) was expressed in Escherichia coli in a soluble form and purified to homogeneity. Spectroscopic data indicate that the conformational properties and the folding pathway of huPrP(90-231) are strongly pH-dependent. Acidic pH induces a dramatic increase in the exposure of hydrophobic patches on the surface of the protein. At pH between 7 and 5, the unfolding of hPrP(90-231) in guanidine hydrochloride occurs as a two-state transition. This contrasts with the unfolding curves at lower pH values, which indicate a three-state transition, with the presence of a stable protein folding intermediate. While the secondary structure of the native huPrP(90-231) is largely alpha-helical, the stable intermediate is rich in beta-sheet structure. These findings have important implications for understanding the initial events on the pathway toward the conversion of the normal into the pathological forms of prion protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346881     DOI: 10.1074/jbc.272.44.27517

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  A general approach to renaturation of recombinant proteins produced as inclusion bodies.

Authors:  A N Wulfson; R V Tikhonov; S E Pechenov
Journal:  Dokl Biochem Biophys       Date:  2001 Sep-Oct       Impact factor: 0.788

Review 4.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

Review 5.  Cytolytic toxin Cyt1A and its mechanism of membrane damage: data and hypotheses.

Authors:  Peter Butko
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

6.  The peculiar nature of unfolding of the human prion protein.

Authors:  Ilia V Baskakov; Giuseppe Legname; Zygmunt Gryczynski; Stanley B Prusiner
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

7.  Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.

Authors:  Masakazu Sekijima; Chie Motono; Satoshi Yamasaki; Kiyotoshi Kaneko; Yutaka Akiyama
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

8.  Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.

Authors:  Roger S Armen; Mari L DeMarco; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

9.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Sagar D Khare; Michael Caplow; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.